✦ LIBER ✦

Randomized, phase II study of topotecan/paclitaxel versus cisplatin/etoposide in patients with untreated, extensive disease, small cell lung cancer (SCLC)

✍ Scribed by H. Lena; J. Breton; W. Yu; K. Steppert; K. Lightcap; G. Ross; M. Lymboura

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised Phase II study of topotecan/c

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Cisplatin–etoposide alternating with top

✍ Mavroudis, D; Veslemes, M; Kouroussis, Ch; Tzanakis, N; Ferdoutsis, E; Toumbis, 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 97 KB

O-156 Randomized, phase III trial compar

✍ Langer, C.; Hanna, N.; Einhorn, L.; Sandler, A.; Ansari, R.; Ellis, P.; Byrne, M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 278 KB

The sequential administration of cisplat

✍ D. Mavroudis; S. Agelaki; Ph. Palamidas; Ch. Kouroussis; A. Harpidou; M. Toubis; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

P-558 Phase-II trial of topotecan and et

✍ Reck, Martin; Buchholz, Erika; Groth, Gesine; Kaubitzsch, Sabine; Gatzemeier, Ul 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 190 KB

A multicenter randomized phase III study

✍ Mavroudis, D; Papadakis, E; Veslemes, M; Agelidou, M; Tsiafaki, X; Agelidou, G; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB